Lixte Biotechnology Holdings, Inc.https://investorshangout.com/Lixte-Biotechnology-Holdings-Inc-LIXT-63792/en-usSun, 06 Sep 2026 04:22:34 GMTCopyright InvestorsHangout.comNetworkNewsWire: NetworkNewsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Completes NOMAD Merger, Chanhttps://investorshangout.com/post/view?id=6836288https://investorshangout.com/post/view?id=6836288Thu, 02 Jul 2026 20:48:28 GMTNetworkNewsWire: NetworkNewsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Unlocking New Potential in Phttps://investorshangout.com/post/view?id=6826413https://investorshangout.com/post/view?id=6826413Fri, 24 Apr 2026 20:53:38 GMTNetworkNewsWire: Precision Oncology Is Shifting Toward Combination Strategies, Ultimately Changing How New Therapihttps://investorshangout.com/post/view?id=6824929https://investorshangout.com/post/view?id=6824929Fri, 17 Apr 2026 20:52:46 GMTNetworkNewsWire: Precision Oncology Is Shifting Toward Combination Strategies, Ultimately Changing How New Therapihttps://investorshangout.com/post/view?id=6824928https://investorshangout.com/post/view?id=6824928Fri, 17 Apr 2026 20:51:32 GMTNetworkNewsWire: NetworkNewsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Positions LB-100 as Novel Aphttps://investorshangout.com/post/view?id=6824924https://investorshangout.com/post/view?id=6824924Fri, 17 Apr 2026 20:33:41 GMTNetworkNewsWire: Compact Proton Therapy Delivery Helps Make the Treatment More Accessible for Cancer Patients https://investorshangout.com/post/view?id=6824495https://investorshangout.com/post/view?id=6824495Wed, 15 Apr 2026 20:52:44 GMTNetworkNewsWire: NetworkNewsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Reports Interim Ovarian Canchttps://investorshangout.com/post/view?id=6824108https://investorshangout.com/post/view?id=6824108Mon, 13 Apr 2026 20:37:19 GMTNetworkNewsWire: LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Accelerates Cancer Care Innovation with Liora Tehttps://investorshangout.com/post/view?id=6823796https://investorshangout.com/post/view?id=6823796Fri, 10 Apr 2026 21:10:59 GMTNetworkNewsWire: Lixte Biotech Holdings Inc. (NASDAQ: LIXT) Advances Precision Oncology Strategy with LB-100, Expahttps://investorshangout.com/post/view?id=6823658https://investorshangout.com/post/view?id=6823658Thu, 09 Apr 2026 21:13:11 GMTNetworkNewsWire: Lixte Biotech Holdings Inc. (NASDAQ: LIXT) Advances Precision Oncology Strategy with LB-100, Expahttps://investorshangout.com/post/view?id=6823656https://investorshangout.com/post/view?id=6823656Thu, 09 Apr 2026 21:07:28 GMTNetworkNewsWire: NetworkNewsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Files 2025 Form 10-K, Highlihttps://investorshangout.com/post/view?id=6822641https://investorshangout.com/post/view?id=6822641Wed, 01 Apr 2026 20:51:53 GMTNetworkNewsWire: LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Has the World’s Only Clinical-Stage PP2A Inhibithttps://investorshangout.com/post/view?id=6822443https://investorshangout.com/post/view?id=6822443Tue, 31 Mar 2026 20:22:35 GMTNetworkNewsWire: LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Strengthens Oncology Pipeline Through Expanded Lhttps://investorshangout.com/post/view?id=6822250https://investorshangout.com/post/view?id=6822250Mon, 30 Mar 2026 20:35:48 GMTNetworkNewsWire: Lixte Biotech Holdings Inc. (NASDAQ: LIXT) Advances Precision Oncology with LB-100, Strengthens Phttps://investorshangout.com/post/view?id=6821779https://investorshangout.com/post/view?id=6821779Thu, 26 Mar 2026 21:10:34 GMTNetworkNewsWire: Landmark Proton Therapy Data Changes the Conversation; LIXTE Saw It Coming - A landmark Phhttps://investorshangout.com/post/view?id=6821383https://investorshangout.com/post/view?id=6821383Tue, 24 Mar 2026 21:19:33 GMTNetworkNewsWire: LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Advances PP2A Inhibition Strategy in Evolving Onhttps://investorshangout.com/post/view?id=6820893https://investorshangout.com/post/view?id=6820893Fri, 20 Mar 2026 21:05:58 GMTNetworkNewsWire: Investing in Innovation: Evaluating the Clinical and Commercial Potential of LB-100 and Liora’s Phttps://investorshangout.com/post/view?id=6820198https://investorshangout.com/post/view?id=6820198Mon, 16 Mar 2026 21:06:42 GMTNetworkNewsWire: LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Expands LB 100 Development Through Strategic Acahttps://investorshangout.com/post/view?id=6819945https://investorshangout.com/post/view?id=6819945Fri, 13 Mar 2026 20:50:56 GMTNetworkNewsWire: Building a New Cancer Care Ecosystem: Liora’s Proton Therapy and LIXTE’s Drug Pipeline in Synergyhttps://investorshangout.com/post/view?id=6819172https://investorshangout.com/post/view?id=6819172Mon, 09 Mar 2026 20:56:54 GMTNetworkNewsWire: LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Advances Lead Compound in Tumor Immunogenicity Rhttps://investorshangout.com/post/view?id=6818814https://investorshangout.com/post/view?id=6818814Fri, 06 Mar 2026 22:32:49 GMTNetworkNewsWire: NetworkNewsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Adds Innovative LiGHT Theraphttps://investorshangout.com/post/view?id=6818805https://investorshangout.com/post/view?id=6818805Fri, 06 Mar 2026 22:11:05 GMTNetworkNewsWire: Liora, a subsidiary of LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT), Introduces New CEO, Brinhttps://investorshangout.com/post/view?id=6817938https://investorshangout.com/post/view?id=6817938Mon, 02 Mar 2026 22:25:11 GMTNetworkNewsWire: LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Expands into Proton Therapy Through Liora Technohttps://investorshangout.com/post/view?id=6816978https://investorshangout.com/post/view?id=6816978Mon, 23 Feb 2026 22:35:49 GMTNetworkNewsWire: LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Focused on Dual Narratives of Scientific Progreshttps://investorshangout.com/post/view?id=6815717https://investorshangout.com/post/view?id=6815717Fri, 13 Feb 2026 22:17:47 GMTNetworkNewsWire: NetworkNewsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Bringing First-in-Class Apprhttps://investorshangout.com/post/view?id=6815310https://investorshangout.com/post/view?id=6815310Wed, 11 Feb 2026 21:34:58 GMTNetworkNewsWire: LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Aligns Liora and the LiGHT System With LB-100 tohttps://investorshangout.com/post/view?id=6814984https://investorshangout.com/post/view?id=6814984Mon, 09 Feb 2026 20:38:54 GMTNetworkNewsWire: NetworkNewsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Positions LB-100 to Expand Ehttps://investorshangout.com/post/view?id=6814695https://investorshangout.com/post/view?id=6814695Fri, 06 Feb 2026 22:23:51 GMTNetworkNewsWire: Improving the Odds: How LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Is Working to Make Cancehttps://investorshangout.com/post/view?id=6814409https://investorshangout.com/post/view?id=6814409Wed, 04 Feb 2026 22:37:16 GMTNetworkNewsWire: LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Advances a Novel Approach to Enhancing Cancer Thhttps://investorshangout.com/post/view?id=6812377https://investorshangout.com/post/view?id=6812377Fri, 23 Jan 2026 08:43:38 GMTNetworkNewsWire: NetworkNewsBreaks – Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) to Participate In DealFlow https://investorshangout.com/post/view?id=6811994https://investorshangout.com/post/view?id=6811994Tue, 20 Jan 2026 21:32:58 GMTNetworkNewsWire: NetworkNewsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Engages IBN to Support Corpohttps://investorshangout.com/post/view?id=6810989https://investorshangout.com/post/view?id=6810989Tue, 13 Jan 2026 21:00:24 GMTNetworkNewsWire: NetworkNewsBreaks – Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) Expands Ovarian Cancer Triahttps://investorshangout.com/post/view?id=6810295https://investorshangout.com/post/view?id=6810295Thu, 08 Jan 2026 21:09:25 GMTNetworkNewsWire: LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Is ‘One to Watch’ - LIXTE is advancing a https://investorshangout.com/post/view?id=6810102https://investorshangout.com/post/view?id=6810102Wed, 07 Jan 2026 23:01:27 GMTNetworkNewsWire: NetworkNewsBreaks – Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) Announces $4.3 Million Regihttps://investorshangout.com/post/view?id=6810098https://investorshangout.com/post/view?id=6810098Wed, 07 Jan 2026 22:28:21 GMTwhytestocks: $LIXT News Article - LIXTE, Netherlands Cancer Institute, and Oncode Institute to Expand Collaboratihttps://investorshangout.com/post/view?id=6633142https://investorshangout.com/post/view?id=6633142Mon, 16 Oct 2023 17:26:00 GMTwhytestocks: $LIXT News Article - LIXTE Biotechnology Announces a Supported Collaborative Trial to Study LIXTE's https://investorshangout.com/post/view?id=6620558https://investorshangout.com/post/view?id=6620558Wed, 20 Sep 2023 14:10:55 GMTznewcar1: $LIXT 38% v4,4M c7.53 f1,665M H9.50 https://investorshangout.com/post/view?id=6597182https://investorshangout.com/post/view?id=6597182Tue, 18 Jul 2023 02:55:10 GMTwhytestocks: $LIXT News Article - Preclinical Results of LIXTE Biotechnology's Collaboration with Netherlands Canhttps://investorshangout.com/post/view?id=6596856https://investorshangout.com/post/view?id=6596856Mon, 17 Jul 2023 14:10:45 GMTwhytestocks: $LIXT News Article - LIXTE Biotechnology Holdings, Inc. Regains Compliance with Nasdaq Continued Lishttps://investorshangout.com/post/view?id=6588918https://investorshangout.com/post/view?id=6588918Fri, 23 Jun 2023 12:45:46 GMTwhytestocks: $LIXT News Article - LIXTE Biotechnology Holdings, Inc. Announces 1-for-10 Reverse Stock Split of ithttps://investorshangout.com/post/view?id=6581780https://investorshangout.com/post/view?id=6581780Fri, 02 Jun 2023 18:05:53 GMTwhytestocks: $LIXT News Article - LIXTE Biotechnology Announces Sarah Cannon Research Institute Joins City of Hophttps://investorshangout.com/post/view?id=6556617https://investorshangout.com/post/view?id=6556617Tue, 04 Apr 2023 16:00:47 GMTwhytestocks: $LIXT News Article - Can Trading Penny Stocks Be a Full Time Job? https://investorshangout.com/post/view?id=6533779https://investorshangout.com/post/view?id=6533779Wed, 08 Feb 2023 13:45:45 GMTznewcar1: $LIXT 133% v49,1M C1.89 f16,646M H2.7 ML.52 LL.43 BO1 pushed to HODhttps://investorshangout.com/post/view?id=6533560https://investorshangout.com/post/view?id=6533560Tue, 07 Feb 2023 21:43:34 GMTwhytestocks: $LIXT News Article - LIXTE Biotechnology Holdings to Present at Planet MicroCap Showcase: VIRTUAL 20https://investorshangout.com/post/view?id=6504692https://investorshangout.com/post/view?id=6504692Wed, 30 Nov 2022 13:10:50 GMTwhytestocks: $LIXT News Article - LIXTE BIOTECHNOLOGY ANNOUNCES APPOINTMENT OF PROFESSOR REN BERNARDS TO ITS BOAhttps://investorshangout.com/post/view?id=6422358https://investorshangout.com/post/view?id=6422358Wed, 15 Jun 2022 20:15:56 GMTwhytestocks: $LIXT News Article - WestPark Capital Announces Completion of $5.8 Million Registered Direct Offerinhttps://investorshangout.com/post/view?id=6383157https://investorshangout.com/post/view?id=6383157Wed, 13 Apr 2022 20:30:57 GMTwhytestocks: $LIXT News Article - WallachBeth Capital Announces Purchase and Sale of LIXTE Biotechnology Holdingshttps://investorshangout.com/post/view?id=6382580https://investorshangout.com/post/view?id=6382580Wed, 13 Apr 2022 12:40:49 GMTznewcar1: LIXT 67% v183M c1.84 f13,7M H4.95 gapNgo then craphttps://investorshangout.com/post/view?id=6382448https://investorshangout.com/post/view?id=6382448Wed, 13 Apr 2022 03:00:25 GMTwhytestocks: $LIXT News Article - LIXT Stock Gets 200%+ Lift, Don't Get Caught on the Way Down https://investorshangout.com/post/view?id=6382333https://investorshangout.com/post/view?id=6382333Tue, 12 Apr 2022 19:30:48 GMTwhytestocks: $LIXT News Article - LIXTE Biotechnology Reports Preclinical Results of Striking Anti-Cancer Activithttps://investorshangout.com/post/view?id=6382104https://investorshangout.com/post/view?id=6382104Tue, 12 Apr 2022 16:20:50 GMT